Clinical cancer research 23 (2016): 2542–2555. doi:10.1158/1078-0432.CCR-15-2388 info:cnr-pdr/source/autori:Nebbioso A., Carafa V, Conte M, Tambaro FP, Abbondanza C, Martens JH, Nees M, Benedetti R, Pallavicini I, Minucci S, Garcia-Manero G, Iovino F, Lania G, Ingenito C, Belsito Petrizzi V, Stunnenberg HG, Altucci L./titolo:c-Myc modulation & acetylation is a key HDAC inhibitor target in cancer/doi:10.1158%2F1078-0432.CCR-15-2388/rivista:Clinical cancer research (Print)/anno:2016/pagina_da:2542/pagina_a:2555/intervallo_pagine:2542–2555/volume:23 Clinical Cancer Research, 23, 2542-2555 Clinical Cancer Research, 23, 10, pp. 2542-2555